[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BiopharmIQ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::811036897883492352.png) BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.7K followers
Created: 2025-07-16 16:16:20 UTC

📌 Biotech Stock News 07/16 @ Open 🧬 📰

$CGTX XX% Clinical Data from Ph2 Study
$ONCY X% Aggregated Data on Pelareorep Effectiveness
$CUE X% Complete Response Data in Ph1 Trial
$RPTX X% Licensing Agreement for Lunresertib
$VYGR X% Adds Fourth Alzheimer's Program to Pipeline
$ADIL X% Regains Compliance with Nasdaq 
$KALV X% UK Approval of HAE Treatment

$OGEN X% Manufacturing Agreement for ONP-002 Development

$TMO -X% Strategic Partnership for Drug Manufacturing
$BCDA -X% Patient Enrollment for CardiAMP HF Study
$ENSC -X% Initiates Ph3 Study of PF614
$QNCX -X% Completes Enrollment in Phase X Trial
$ZVRA -X% OLE Data on MIPLYFFA
$DTIL -X% Preclinical Data for PBGENE-DMD
$OKYO -X% Strong Ph2 Results for Urcosimod
$GANX -X% Pricing of $7M Offering
$PRME -X% Additional Funding for Prime Editing Treatments
$IKNA -X% Stockholder Approval of Merger
$KZR -X% Lifts Clinical Hold on Ph2aTrial
$CTXR -X% Pricing of $9M Offering
$LIXT -XX% Regains Compliance with Nasdaq

See image for more details. 📸

![](https://pbs.twimg.com/media/Gv_bjncXQAAwZbp.png)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945517869774848275/c:line.svg)

**Related Topics**
[alzheimers](/topic/alzheimers)
[$ogen](/topic/$ogen)
[$kalv](/topic/$kalv)
[nasdaq](/topic/nasdaq)
[$adil](/topic/$adil)
[$vygr](/topic/$vygr)
[$rptx](/topic/$rptx)
[$cue](/topic/$cue)

[Post Link](https://x.com/BiopharmIQ/status/1945517869774848275)